25/05/2013 13:24:27 Free Membership Login
Axcan Pharma (MM)
   

   

Axcan Pharmaceuticals, Incorporated

Visual Financials
Axcan Pharma stock quote | Axcan Pharma company information | Axcan Pharma Stock Chart | Axcan Pharma Stock News
Company Name: Axcan Pharmaceuticals, Incorporated
Ticker Symbol: AXCA
WWW Address: www.axcan.com
CEO: Dr.Frank A.G.M. Verwiel
No. of Employees: 480
Common Issue Type: CS
Business Description:A pharmaceutical company concentrating in the field of gastroenterology, with operations in North America and Europe.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 23.34 Unchanged 0.0 - -  23.34 23.31 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,292.4 55.4 1.68 1.33 0.00 16.8 0.0 23.34 - 14.85
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close23.34$
PE Ratio - LTM16.8
Market Capitalisation1,292.4mil
Latest Shares Outstanding55.4mil
Earnings pS (EPS)1.33$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee726,973$
Effective Tax Rate33.2%
Float0.0mil
Float as % of Shares Outstanding0.0%
Foreign Sales311mil
Domestic Sales38mil
Selling, General & Adm/tive (SG&A) as % of Revenue30.80%
Research & Devlopment (R&D) as % of Revenue7.70%
Gross Profit Margin76.1%
EBITDA Margin37.7%
Pre-Tax Profit Margin30.5%
Assets Turnover0.5%
Return on Assets (ROA)8.9%
Return on Equity (ROE)10.6%
Return on Capital Invested (ROCI)10.6%
Current Ratio4.3
Leverage Ratio (Assets/Equity)1.2
Interest Cover30.0
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Total Capital0.0%
Working Capital pS5.87$
Cash pS5.61$
Book-Value pS12.98$
Tangible Book-Value pS5.86$
Cash Flow pS1.79$
Free Cash Flow pS1.96$
KEY FIGURES (LTM): Price info
Price/Book Ratio1.80
Price/Tangible Book Ratio3.98
Price/Cash Flow13.0
Price/Free Cash Flow11.9
P/E as % of Industry Group77.0%
P/E as % of Sector Segment6.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.1998,8334,165
4 Weeks23.3422.7122.752.61047,620114,302
13 Weeks23.3422.1222.583.41127,469425,724
26 Weeks23.3415.8919.0822.31316,514781,667
52 Weeks23.3414.8515.7648.11504,6521,149,028
YTD23.3422.12-1.51096,760250,137
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
23.2923.1722.8520.7320.231.681.33
 
GROWTH RATES5-Year
Growh		R² of 5-Year Growth3-Year
Growth
Revenue17.5794.812.40
Income18.7958.920.47
Dividend0.000.00.00
Capital Spending-17.46NA-15.79
R&D29.89NA10.10
Normalized Inc.19.39NA27.02
 
CHANGESYTD vs.
Last YTD		Curr Qtr vs.
Qtr 1-Yr ago		Annual vs.
Last Annual
Revenue %17.917.919.4
Earnings %27.627.682.7
EPS %14.714.768.4
EPS $0.050.050.54
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio35.72
Current Ratio3.8
Quick Ratio (Acid Test)3.4
Liquidity Ratio (Cash)2.96
Receivables Turnover8.1
Average Collection Period44
Working Capital/Equity43.1
Working Capital pS5.37
Cash-Flow pS1.70
Free Cash-Flow pS2.34
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio6.84
Financial Leverage Ratio (Assets/Equity)1.2
Debt Ratio17.1
Total Debt/Equity (Gearing Ratio)0.00
LT Debt/Equity0.00
LT Debt/Capital Invested5.5
LT Debt/Total Liabilities0.1
Interest Cover23.2
Interest/Capital Invested0.66
 
VALUATION RATIOS
MULTIPLES
PQ Ratio2.99
Tobin's Q Ratio1.55
Current P/E Ratio - LTM16.80
Enterprise Value (EV)/EBITDA8.31
Enterprise Value (EV)/Free Cash Flow10.30
Dividend Yield0.0
Price/Tangible Book Ratio - LTM3.98
Price/Book Ratio - LTM1.80
Price/Cash Flow Ratio13.0
Price/Free Cash Flow Ratio - LTM11.9
Price/Sales Ratio3.56
P/E Ratio (1 month ago) - LTM16.4
P/E Ratio (26 weeks ago) - LTM15.8
P/E Ratio (52 weeks ago) - LTM16.8
5-Y High P/E Ratio36.4
5-Y Low P/E Ratio10.1
5-Y Average P/E Ratio20.6
Current P/E Ratio as % of 5-Y Average P/E82
P/E as % of Industry Group77.0
P/E as % of Sector Segment6.0
Current 12 Month Normalized P/E Ratio - LTM14.9
PER SHARE FIGURES
LT Debt pS0.00
Current Liabilities pS1.89
Tangible Book Value pS - LTM5.86
Book Value pS - LTM12.98
Capital Invested pS12.47
Cash pS - LTM5.61
Cash Flow pS - LTM1.79
Free Cash Flow pS - LTM1.96
Earnings pS (EPS)1.33
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin37.05
Free Cash Flow Margin 5YEAR AVG23.56
Net Profit Margin20.5
Net Profit Margin - 5YEAR AVRG.15.3
Equity Productivity0.51
Return on Equity (ROE)10.4
Return on Equity (ROE) - 5YEAR AVRG.8.6
Capital Invested Productivity0.51
Return on Capital Invested (ROCI)10.4
Return on Capital Invested (ROCI) - 5YEAR AVRG.7.1
Assets Productivity0.50
Return on Assets (ROA)8.6
Return on Assets (ROA) - 5YEAR AVRG.6.0
Gross Profit Margin76.1
Gross Profit Margin - 5YEAR AVRG.75.5
EBITDA Margin - LTM37.7
EBIT Margin - LTM31.5
Pre-Tax Profit Margin30.7
Pre-Tax Profit Margin - 5YEAR AVRG.22.8
Effective Tax Rate33.2
Effective Tax Rate - 5YEAR AVRG.32.6
EFFICIENCY RATIOS
Cash Conversion Cycle186
Revenue per Employee726,973
Net Income per Employee148,885
Average Collection Period48
Receivables Turnover8.1
Day's Inventory Turnover Ratio138
Inventory Turnover2.6
Inventory/Sales7.7
Accounts Payble/Sales3.90
Assets/Revenue2.00
Net Working Capital Turnover1.17
Fixed Assets Turnover0.81
Total Assets Turnover0.5
Revenue per $ Cash1.94
Revenue per $ Plant11.19
Revenue per $ Common Equity0.51
Revenue per $ Capital Invested0.51
Selling, General & Adm/tive (SG&A) as % of Revenue29.0
SG&A Expense as % of Revenue - 5YEAR AVRG.31.9
Research & Devlopment (R&D) as % of Revenue8.2
R&D Expense as % of Revenue - 5YEAR AVRG.8.2

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's

1 site:2 us nasdaq axca130525 13:24